Global CMO Peptide Market Growth (Status and Outlook) 2025-2031

The global CMO Peptide market size is predicted to grow from US$ 3997 million in 2025 to US$ 9492 million in 2031; it is expected to grow at a CAGR of 15.5% from 2025 to 2031.

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

The customized peptide synthesis market is driven by the growing demand for peptides in various fields, including pharmaceuticals, biotechnology, and research. Customized peptides are essential tools for drug development, therapeutic applications, and biochemical research. The increasing focus on personalized medicine and targeted therapies further propels market growth. Moreover, advancements in peptide synthesis technologies and the availability of automated synthesis platforms have improved the efficiency and scalability of customized peptide production. However, challenges include the complexity of synthesizing certain peptides, the need for stringent quality control measures, and the cost associated with custom synthesis services. Addressing these challenges through continuous research and development, process optimization, and competitive pricing will be crucial for sustaining the growth of the customized peptide synthesis market.

LPI (LP Information)' newest research report, the “CMO Peptide Industry Forecast” looks at past sales and reviews total world CMO Peptide sales in 2024, providing a comprehensive analysis by region and market sector of projected CMO Peptide sales for 2025 through 2031. With CMO Peptide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CMO Peptide industry.

This Insight Report provides a comprehensive analysis of the global CMO Peptide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CMO Peptide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CMO Peptide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CMO Peptide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CMO Peptide.

This report presents a comprehensive overview, market shares, and growth opportunities of CMO Peptide market by product type, application, key players and key regions and countries.

Segmentation by Type:
APIs and Intermediates
FDF

Segmentation by Application:
Commercial
Academic Research
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem
PolyPeptide
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
AmbioPharm
SN Biopharm
CBL
Piramal Pharma
CordenPharma
CPC Scientific

Please note: The report will take approximately 2 business days to prepare and deliver.